U.S. market Closed. Opens in 2 hours 58 minutes

GRNAW | GreenLight Biosciences Holdings Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue6.38MN/A962.00K3.00M
Cost of RevenueN/AN/AN/AN/A
Gross Profit6.38MN/A962.00K3.00M
Operating Expenses169.34M108.56M53.25M32.20M
Selling, General & Admin35.93M20.32M11.16M8.71M
Research & Development133.81M89.83M42.87M23.49M
Other Operating Expenses-396.00K-1.59M-785.00KN/A
Operating Income-163.92M-108.56M-52.28M-29.20M
Other Expenses / Income-2.04M-3.75M-967.00K553.00K
Before Tax Income-165.96M-112.31M-53.25M-28.65M
Income Tax Expenses1.09M2.42M1.03M317.00K
Net Income-167.06M-114.73M-54.28M-28.97M
Interest Expenses4.12M2.42M1.03M317.00K
Basic Shares Outstanding131.98M122.82M96.35M96.35M
Diluted Shares Outstanding131.98M122.82M96.35M96.35M
EBITDA-153.99M-102.75M-50.45M-27.65M
EBITDA Margin-2,412.11%0.00%-5,243.97%-921.33%
EBIT-161.84M-109.89M-52.22M-28.33M
EBIT Margin-2,535.09%0.00%-5,428.59%-944.09%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙